What is Zacks Research’s Forecast for Revvity Q4 Earnings?

Revvity, Inc. (NYSE:RVTY) – Investment analysts at Zacks Research reduced their Q4 2025 EPS estimates for shares of Revvity in a note issued to investors on Monday, April 14th. Zacks Research analyst R. Department now anticipates that the company will earn $1.49 per share for the quarter, down from their prior estimate of $1.50. The consensus estimate for Revvity’s current full-year earnings is $4.94 per share. Zacks Research also issued estimates for Revvity’s Q3 2026 earnings at $1.44 EPS and Q4 2026 earnings at $1.56 EPS.

Several other equities analysts also recently commented on the stock. Barclays decreased their price target on shares of Revvity from $140.00 to $110.00 and set an “overweight” rating on the stock in a research note on Thursday, April 10th. Wells Fargo & Company lowered their target price on shares of Revvity from $130.00 to $102.00 and set an “equal weight” rating on the stock in a report on Thursday. KeyCorp boosted their price target on Revvity from $132.00 to $145.00 and gave the company an “overweight” rating in a research note on Monday, February 3rd. Raymond James restated an “outperform” rating and set a $145.00 price objective (up previously from $140.00) on shares of Revvity in a research note on Monday, February 3rd. Finally, Sanford C. Bernstein downgraded Revvity from an “outperform” rating to a “market perform” rating and set a $130.00 target price for the company. in a research report on Friday, January 10th. Four analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $131.42.

Revvity Stock Performance

Shares of NYSE RVTY opened at $91.82 on Thursday. Revvity has a one year low of $89.61 and a one year high of $129.50. The company has a debt-to-equity ratio of 0.41, a current ratio of 3.60 and a quick ratio of 3.03. The firm has a market cap of $11.03 billion, a price-to-earnings ratio of 41.55, a P/E/G ratio of 3.82 and a beta of 1.07. The stock’s fifty day moving average price is $107.18 and its two-hundred day moving average price is $114.37.

Revvity (NYSE:RVTY) last posted its earnings results on Friday, January 31st. The company reported $1.42 EPS for the quarter, beating the consensus estimate of $1.37 by $0.05. Revvity had a return on equity of 7.68% and a net margin of 9.81%. During the same period in the prior year, the business earned $1.25 EPS.

Revvity Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Stockholders of record on Friday, April 18th will be issued a $0.07 dividend. The ex-dividend date is Thursday, April 17th. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.30%. Revvity’s dividend payout ratio (DPR) is currently 12.67%.

Insider Activity

In related news, insider Joel S. Goldberg sold 15,170 shares of the stock in a transaction that occurred on Thursday, January 30th. The shares were sold at an average price of $126.73, for a total value of $1,922,494.10. Following the completion of the transaction, the insider now owns 33,400 shares of the company’s stock, valued at $4,232,782. This represents a 31.23 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.68% of the stock is currently owned by corporate insiders.

Institutional Trading of Revvity

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Janney Montgomery Scott LLC increased its stake in shares of Revvity by 39.4% in the first quarter. Janney Montgomery Scott LLC now owns 10,998 shares of the company’s stock valued at $1,164,000 after buying an additional 3,107 shares during the period. Ritholtz Wealth Management bought a new stake in shares of Revvity in the 1st quarter valued at about $210,000. Wealth Enhancement Advisory Services LLC increased its stake in shares of Revvity by 3.8% in the first quarter. Wealth Enhancement Advisory Services LLC now owns 5,139 shares of the company’s stock valued at $544,000 after buying an additional 187 shares during the period. Pullen Investment Management LLC acquired a new position in shares of Revvity in the first quarter worth approximately $377,000. Finally, GAMMA Investing LLC raised its holdings in Revvity by 42.9% during the 1st quarter. GAMMA Investing LLC now owns 2,713 shares of the company’s stock worth $287,000 after purchasing an additional 815 shares during the last quarter. Institutional investors own 86.65% of the company’s stock.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.